BIOCORP Signs Two New Partnerships With Mallya Technology
BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the design, development and manufacturing of innovative medical devices, today announces the signature of new partnerships with Health2Sync and SocialDiabetes, companies headquartered in Taiwan and Spain, respectively.
These two partnerships involve the integration of Mallya, the connected device dedicated to insulin pens, with the digital applications developed by Health2Sync and SocialDiabetes to improve the quality of care for patients with diabetes.
In detail, the platform developed by SocialDiabetes (CE marked and FDA 510K) allows self-monitoring of insulin doses and offers personalized recommendations to patients. All of the data collected feeds a telemedicine platform using augmented intelligence for physicians and specialized call centers. To date, this platform is used by 250,000 patients with diabetes, mainly in Spain, Mexico, Colombia and Chile.
Health2Sync’s app, through its analytics engine, provides personalized recommendations and nudges concerning meals, exercise, and blood glucose management, delivered in a compelling way that encourages users to stay adherent to treatment plans. Health2Sync’s Patient Management Platform utilizes decision support modules for healthcare providers to deliver effective interventions that are also scalable, with insulin dosing as an example. The patient management platform is deployed in over 260 of diabetes care institutions in Taiwan, Malaysia and Japan, and the mobile app is used by more than 600,000 patients in Taiwan, Japan, USA, Hong Kong, Malaysia, Singapore and Australia.
Patients using these digital solutions will be able to automatically synchronize the data recorded by their Mallya sensor, thus benefiting from a complete monitoring offer combining glycemic data analysis and insulin dose feedback. This information can be transmitted in real time to treating physicians via a devoted portal to improve the quality of dialogue with patients, optimize treatment plans and offer personalized recommendations.
Éric Dessertenne, CEO of BIOCORP, explained: “These new partnerships come at a time when our teams are preparing for the large-scale commercial launch of Mallya, which is already compatible with almost all disposable pens on the market. Its integration with the most widely used applications in local markets is a great advantage for the rapid adoption of Mallya in these countries. Health2Sync and SocialDiabetes will enable us to accelerate our penetration in Asia and some Latin American countries, geographical areas where the diabetic population and the use of connected medicine are highly developed".
”Health2Sync bridges the lengthy gap between doctor visits by enabling frequent digital touch points between patients and healthcare providers. Insulin dosing data captured by Mallya will significantly enhance the experience of patients on insulin “said Ed Deng, Co-Founder and CEO of Health2Sync. “We expect better adherence and improved outcomes that come as a result of making data available to patients and healthcare providers.”
“We are thrilled to initiate this agreement with Biocorp. Mallya sensor is a world-class player and represents the type of high-quality technology we want to bring to our customers. Patients increasingly demand combined solutions that provide them with high connectivity and data driven personalized support. This alliance with Biocorp is a big step toward the digital health ecosystem the market is waiting for. “said María Jesús Salido, cofounder & CEO of Social Diabetes.
Founded in 2013, Health2Sync provides a comprehensive health-management platform for people with chronic conditions. Its products combine mobile, cloud, and data analytics, enabling patients to obtain personalized care and allows care providers and family to care for patients remotely. With the largest network of clinics and hospitals, it is the leading solution in Asia that brings an effective, yet scalable solution to diabetes management.
For more information, please visit https://www.health2sync.com
ABOUT SOCIAL DIABETES
SocialDiabetes is set to become one of the best solutions to foster the digital management of diabetes. Leader in Spanish speaking markets, the company, headquartered in Barcelona with offices in the UK, and Ciudad de Mexico was first created to meet the needs of Victor Bautista, a Type 1 diabetes patient and current CTO & co-founder. A company of patients working for patients, SocialDiabetes provides a system that synchronizes with multiple devices, easily connect patients with the healthcare professionals that are treating them and provides relevant information for decision making in one place.
For more information, please visit www.socialdiabetes.com
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This smart sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of patients with diabetes. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions. The company has 70 employees.
BIOCORP is listed on Euronext since July 2015 (FR0012788065 – ALCOR).
For more information, please visit www.biocorpsys.com.
Chairman of the Board
Chief Executive Officer
Marketing & Communication Director
+ 33 (0)6 88 69 72 85
+33 (0)6 87 88 46 26
+33 (0)6 63 66 59 22
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Universal Peace Federation: Millions of participants from 150 countries joined the live online broadcast of the 5 th Rally of Hope3.3.2021 19:43:00 CET | Press release
Millions of participants from 150 countries joined the live online broadcast of the 5th Rally of Hope sponsored by the Universal Peace Federation (UPF) on Saturday, February 27, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005853/en/ Dr. Hak Ja Han Moon, Co-Founder of Universal Peace Federation delivering her message of peace to the online participants of the 5th Rally of Hope. (Photo: Business Wire) The virtual event featured world-class entertainment and globally renowned leaders including Cape Verde President Jorge Carlos Fonseca; Guyana Prime Minister Mark Phillips; U.S. Vice President Mike Pence (2017-2021); United Nations World Food Programme Executive Director David Beasley; City of Refuge Church Bishop Noel Jones; South Africa President F.W. de Klerk (1989-1994); India Vice President Mohammad Hamid Ansari (2007-2017); Oxford Vaccine co-developer Dr. Sarah Gilbert; and East Timor President Xanana Gusmão
AGCO Announces Farmer-First Strategy3.3.2021 17:50:00 CET | Press release
AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, today announced its farmer-first strategy designed to maximize value creation for its key stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005773/en/ AGCO Announces Farmer-First Strategy (Photo: Business Wire) During its 2021 Virtual Analyst Briefing, Eric Hansotia, AGCO’s Chairman, President and CEO introduced AGCO’s new Purpose and Vision statements that, when combined, offer powerful insight into the role AGCO intends to play for farmers and within the agriculture industry. AGCO’s Purpose is to deliver “Farmer-focused solutions to sustainably feed our world” and its Vision is to be the “Trusted partner for industry-leading, smart farming solutions.” AGCO will realize its Purpose and Vision by continuing to leverage its award-winning, differentiated brand portfolio to offer
Norwegian Emergency Health Services Gain Nationwide Collaboration Through Motorola Solutions’ Unified Control Room Solution3.3.2021 17:27:00 CET | Press release
Health services are a critical discipline, where every second counts and the control room is at the heart of their mission-critical operations. Teams require collaboration and flexibility to effectively manage emergency health situations as they arise. This has become especially apparent with the ongoing COVID-19 pandemic, where pressures on health services including medical communication centres, continue to rise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005158/en/ (Photo: Business Wire) Motorola Solutions announced today it has been awarded a contract by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to provide the Norwegian Health Emergency Service with a new CommandCentral Control Room Solution (CRS). “The new control room solution allows for significant improvements to efficiency and scalability, providing the much-needed flexibility between mission-critical teams”, said Lars Erik Tandsæther, CEO
H.I.G. Capital Expands European WhiteHorse Team with the Addition of Michael Lucas3.3.2021 17:08:00 CET | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with over €35 billion of equity capital under management, is pleased to announce the expansion of its European WhiteHorse team with the addition of Michael Lucas as a Managing Director. Michael will be based in H.I.G.’s London office. Michael has 27 years of experience in leveraged finance and direct lending. Prior to joining H.I.G., he was a Founding Partner and Head of the UK at Bridgepoint Credit. Prior to that, he spent over 20 years at ING where he was most recently acting as Global Head of Financial Sponsors. Commenting on the hire, Pascal Meysson, Head of H.I.G. WhiteHorse Europe, said, “We are thrilled to have Michael join the firm. He is one of the most respected and well-known professionals within the direct lending community in Europe, and I am confident he will have an immediate impact on our growing European direct lending platform.” About H.I.G. Capital H.I.G. is a leading global alternative asse
NZMP™ Customers Set to Benefit From New Carbonzero Certified Ingredients3.3.2021 17:00:00 CET | Press release
NZMP™, Fonterra’s dairy ingredient and solutions brand, has launched a new carbonzero certified Organic Butter. Debuting its launch in North America, the new Organic Butter will help NZMP’s customers to achieve their own sustainability goals and meet consumer demand for more sustainable products. With 72 per cent of global consumers expressing an interest in brands that actively communicate achievements around sustainability1, the introduction of carbonzero ingredients is just one way in which NZMP™ customers can leverage Fonterra’s sustainability solutions. NZMP’s™ first certified carbonzero ingredient has been audited and verified by Toitū Envirocare, an independent certifier. Lara Phillips, Senior Manager of Fonterra Sustainability Solutions, says: “Climate change is one of the most pressing challenges of our time and we’re committed to finding solutions to reduce our footprint further as part of our ongoing journey in sustainability. “To obtain carbonzero certification for an ingre
CORRECTING and REPLACING Monument Re Acquires Variable Annuity Portfolio From Athora Ireland Plc.3.3.2021 16:07:00 CET | Press release
Headline of release should read: Monument Re Acquires Variable Annuity Portfolio From Athora Ireland Plc. (instead of Monument Re Acquires Variable Annuity Portfolio From Athora Life Plc.). The updated release reads: MONUMENT RE ACQUIRES VARIABLE ANNUITY PORTFOLIO FROM ATHORA IRELAND PLC. Monument Re announced today that, subject to necessary Irish High Court and regulatory approvals, it has agreed to acquire the closed-block portfolio of variable annuities from Athora Ireland plc, a wholly-owned subsidiary of Athora Holding Ltd. Financial terms of the transaction were not disclosed. “We are pleased to have reached agreement with Athora to acquire this block of business which further reinforces our position as the market leading consolidator in Ireland,” said Manfred Maske, CEO of Monument Re. About Athora Holding Ltd. Athora is a specialised insurance and reinsurance group fully focused on the European market. Athora dedicates its focus, capital, time and technical insights to offerin
Altasciences Conducts Phase I Study in Healthy Normal Subjects for RLS-0071 for Treatment of Acute Lung Injury Due to COVID-19 Pneumonia3.3.2021 15:41:00 CET | Press release
Altasciences is pleased to support ReAlta Life Sciences by conducting a Phase I trial to evaluate RLS-0071 for treatment of Acute Lung Injury (ALI) as a result of viral infections, such as COVID-19, respiratory syncytial virus (RSV), and influenza. As part of the ReAlta ALI program underway, the Phase I trial is a single-ascending dose, randomized, double-blind, placebo-controlled, adaptive-design study to evaluate the safety, tolerability, PK, and PD of RLS-0071 in healthy subjects, performed at the Altasciences clinical pharmacology unit in Montreal, Canada. Ingrid Holmes, Vice President, Global Clinical Operations at Altasciences, says, “Our teams are proud to have the opportunity to be involved in the clinical conduct and bioanalytical analysis for this important first-in-human trial. Being able to prioritize COVID-19 therapies by contributing critical data to the development of potentially life-altering medications, such as RLS-0071, is tremendously rewarding to our teams.” Click
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom